Nexbio, Inc.

Calculating rank

USPTO Granted Patents = 4

Forward Citations = 43

Loading Chart...

5 inventors (with patents filed for the assignee):

Fang Fang (4 out of 14 patents)

Michael P Malakhov (4 out of 15 patents)

David Wurtman (1 out of 1 patent)

4. Ron Moss (1 out of 1 patent)

5. Mang Yu (1 out of 10 patents)

4 patents: Sort by Forward Citations

1. 8398971 - Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract (2013-03-19),

2. 8084036 - Broad spectrum anti-viral therapeutics and prophylaxis (2011-12-27),

3. 7807174 - Class of therapeutic protein based molecules (2010-10-05),

4. 7645448 - Class of therapeutic protein based molecules (2010-01-12),

Company Overview

Nexbio, Inc. is a biotechnology company focused on developing innovative treatments for a range of diseases. Our cutting-edge research and development efforts aim to bring breakthrough therapies to patients in need. With a team of experienced scientists and a commitment to advancing science, Nexbio is dedicated to making a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#1,009 in San Diego, CA

#14,086 in California

#60,778 in US

San Diego, CA, United States of America

Nexbio, Inc.

Forward Citations = 43

5 inventors:

Fang Fang (4 out of 14 patents)

Michael P Malakhov (4 out of 15 patents)

David Wurtman (1 out of 1 patent)

4. Ron Moss (1 out of 1 patent)

5. Mang Yu (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nexbio, Inc.. Retrieved from https://idiyas.com/company/nexbio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]